Engineering Organ-on-a-Chip Systems for Vascular Diseases

Area of Science:

• Biomedical Engineering
• Vascular Biology
• Regenerative Medicine

Background:

• Vascular diseases, including atherosclerosis and thrombosis, are leading global causes of illness and death.
• Traditional in vitro models fail to replicate the intricate in vivo microenvironment crucial for studying these diseases.
• Organ-on-a-chip technology presents a novel microscale platform for more accurate vascular disease modeling.

Purpose of the Study:

• To review recent engineering advancements in organ-on-a-chip systems for modeling vascular diseases.
• To highlight the incorporation of microfluidic channels, extracellular matrix (ECM) scaffolds, and patient-specific cells.
• To discuss current limitations and future directions for organ-on-a-chip applications in vascular disease research.

Main Methods:

• Utilizing microfluidic channels to mimic blood vessel structures and flow dynamics.
• Incorporating extracellular matrix (ECM) scaffolds to provide a supportive microenvironment.
• Employing patient-specific cells to enhance the translational relevance of the models.

Main Results:

• Organ-on-a-chip systems successfully integrate multiple cell types and microenvironmental cues.
• These platforms allow for the study of vascular disease mechanisms under physiologically relevant conditions.
• Advancements enable the recapitulation of key aspects of atherosclerosis and thrombosis in vitro.

Conclusions:

• Organ-on-a-chip systems represent a significant improvement over traditional models for vascular disease research.
• Further development holds promise for personalized medicine and drug discovery in vascular diseases.
• Continued innovation in engineering these platforms will enhance their utility and impact on understanding and treating vascular conditions.